Novo Nordisk Research Center Gladsaxe ApS — Credit Rating and Financial Key Figures

Novo Nordisk Research Center Gladsaxe ApS (CVR number: 39119374) is a company from GLADSAXE. The company recorded a gross profit of 515 mDKK in 2023. The operating profit was 514.8 mDKK, while net earnings were 395.5 mDKK. The profitability of the company measured by Return on Assets (ROA) was 194.8 %, which can be considered excellent and Return on Equity (ROE) was 191.3 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 78.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Novo Nordisk Research Center Gladsaxe ApS's liquidity measured by quick ratio was 4.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.